Skip to main content
Fig. 1 | BMC Research Notes

Fig. 1

From: Using the contribution matrix to evaluate complex study limitations in a network meta-analysis: a case study of bipolar maintenance pharmacotherapy review

Fig. 1

Network of eligible comparisons in the multiple-treatment meta-analysis for any mood episode relapse. Each node (circle) corresponds to a drug included in the analyses, with the size proportional to the number of participants assigned to that drug. Each line represents different comparisons between drugs, with the width of the line proportional to the number of trials comparing each pair of treatments. ARP aripiprazole, CBZ carbamazepine, FLX fluoxetine, IMP imipramine, LIT lithium, LTG lamotrigine, OLZ olanzapine, OXC oxcarbazepine, PAL paliperidone, PLB placebo, QTP quetiapine, RisLAI risperidone long-acting injection, VPA valproate

Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us